{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-102041","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2023-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.784645+00:00","generated_at":"2026-06-17T01:47:08.205014+00:00","sec_items":["2.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"WW International completes $132M acquisition of telehealth platform Sequence","bullets":["Total consideration $132M: ~$64.2M cash (incl. $25.8M of Sequence cash), ~$34.7M stock (8M shares at $4.34), plus $16M deferred on each of Apr 10, 2024 and 2025.","Sequence is a subscription telehealth platform providing access to healthcare providers specializing in chronic weight management and insurance navigation.","CEO Sima Sistani cites expansion into clinical weight management medications as a natural next step, leveraging WeightWatchers' core strengths.","Company intends to file required financial statements for Sequence and pro forma information within 71 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-102041","json":"https://secwatch.observer/filing/0001193125-23-102041.json","markdown":"https://secwatch.observer/filing/0001193125-23-102041.md","text":"https://secwatch.observer/filing/0001193125-23-102041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/0001193125-23-102041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/d483518d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:47:08.205014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"77f753b0017e1af3d7d04675016a851316aa641b","claim":"WW INTERNATIONAL, INC. completed an acquisition involving Weekend Health, Inc., doing business as Sequence for an aggregate amount equal to $132.0 million (closed 2023-04-10).","evidence_excerpt":"Health continued as a wholly-owned subsidiary of the Company (the “Acquisition”). As consideration for the Acquisition, the Company agreed to pay an aggregate amount equal to $132.0 million, subject to the adjustments set forth in the Merger Agreement (the “Merger Consideration”). Subject to the terms and conditions of the Merger Agreement, the Merger Consideration","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/105319/000119312523102041/0001193125-23-102041-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Weekend Health, Inc., doing business as Sequence"},{"label":"Consideration","value":"an aggregate amount equal to $132.0 million"},{"label":"Closing","value":"2023-04-10"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}